HIV-1 Inhibits Long-Term Potentiation and Attenuates Spatial Learning

Annals of Neurology

Volumn 55, Issue 3, 2004, Pages 362-371

  Li, Sheng Tian ^a,c   Matsushita, Masayuki ^a   Moriwaki, Akiyoshi ^a   Saheki, Yasunori ^a   Lu, Yun Fei ^b   Tomizawa, Kazuhito ^a   Wu, Hai Yan ^a   Terada, Hiroaki ^a   Matsui, Hideki ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EVIDENCE BASED MEDICINE; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEARNING; LONG TERM POTENTIATION; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SPATIAL LEARNING; SYNAPTIC TRANSMISSION;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BICUCULLINE; CALCIUM; CELLS, CULTURED; DIZOCILPINE MALEATE; DRUG INTERACTIONS; ELECTRIC STIMULATION; EMBRYO; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GABA ANTAGONISTS; GENE PRODUCTS, TAT; HIPPOCAMPUS; HIV-1; INJECTIONS, INTRAVENTRICULAR; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; MICE; MICROSCOPY, CONFOCAL; N-METHYLASPARTATE; NEURAL CONDUCTION; NEURONS; PATCH-CLAMP TECHNIQUES; PEPTIDES; SPATIAL BEHAVIOR; TIME FACTORS;

EID: 1442329318     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10844     Document Type: Article

References (40)

1. Navia BA, Jordan BD, Price RW. The AIDS dementia complex. I. Clinical features. Ann Neurol 1986;19:517-524.
2. Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol 1987;44:65-69.
3. Kure K, Llena JF, Lyman WD, et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 1991;22:700-710.
4. Lipton SA. Neuronal injury associated with HIV-1: approaches to treatment. Annu Rev Pharmacol Toxicol 1998;38:159-177.
5. Nath A, Geiger J. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol 1998;54:19-33.
6. Hudson L, Liu J, Nath A, et al. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol 2000;6:145-155.
7. Magnuson DS, Knudsen BE, Geiger JD, et al. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 1995;37:373-380.
8. Nath A, Psooy K, Martin C, et al. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 1996;70:1475-1480.
9. New DR, Ma M, Epstein LG, et al. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol 1997;3:168-173.
10. New DR, Maggirwar SB, Epstein LG, et al. HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism. J Biol Chem 1998;273:17852-17858.
11. Perez A, Probert AW, Wang KK, Sharmeen L. Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. J Neurovirol 2001;7:1-10.
12. Cheng J, Nath A, Knudsen B, et al. Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein. Neuroscience 1998;82:97-106.
13. Haughey NJ, Holden CP, Nath A, Geiger JD. Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. J Neurochem 1999;73:1363-1374.
14. Haughey NJ, Nath A, Mattson MP, et al. HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 2001;78:457-467.
15. Kolson DL, Buchhalter J, Collman R, et al. HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Res Hum Retroviruses 1993;9:677-685.
16. Orsini MJ, Debouck CM, Webb CL, Lysko PG. Extracellular human immunodeficiency virus type 1 Tat protein promotes aggregation and adhesion of cerebellar neurons. J Neurosci 1996;16:2546-2552.
17. Hayman M, Arbuthnott G, Harkiss G, et al. Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience 1993;53:1-6.
18. Philippon V, Vellutini C, Gambarelli D, et al. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology 1994;205:519-529.
19. Sabatier JM, Vives E, Mabrouk K, et al. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol 1991;65:961-967.
20. Wang P, Barks JD, Silverstein FS. Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats. Neuroscience 1999;88:585-597.
21. Li ST, Kato K, Tomizawa K, et al. Calcineurin plays different roles in group II metabotropic glutamate receptor- and NMDA receptor-dependent long-term depression. J Neurosci 2002;22: 5034-5041.
22. Matsushita M, Tomizawa K, Moriwaki A, et al. A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. J Neurosci 2001; 21:6000-6007.
23. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988;55:1189-1193.
24. Howcroft TK, Strebel K, Martin MA, Singer DS. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 1993;260:1320-1322.
25. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999;285:1569-1572.
26. Ho A, Schwarze SR, Mermelstein SJ, et al. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res 2001;61:474-477.
27. Zucker RS. Short-term synaptic plasticity. Annu Rev Neurosci 1989;12:13-31.
28. Lozovaya NA, Kopanitsa MV, Boychuk YA, Krishtal OA. Enhancement of glutamate release uncovers spillover-mediated transmission by N-methyl-D-aspartate receptors in the rat hippocampus. Neuroscience 1999;91:1321-1330.
29. Lu W, Man H, Ju W, et al. Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 2001;29:243-254.
30. Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 2002;5:405-414.
31. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993;361:31-39.
32. Tovar KR, Westbrook GL. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci 1999;19:4180-4188.
33. Li B, Chen N, Luo T, et al. Differential regulation of synaptic and extra-synaptic NMDA receptors. Nat Neurosci 2002;5:833-834.
34. Nicoll RA, Malenka RC. Expression mechanisms underlying NMDA receptor-dependent long-term potentiation. Ann NY Acad Sci 1999;868:515-525.
35. Kato K, Li ST, Zorumski CF. Modulation of long-term potentiation induction in the hippocampus by N-methyl-D-aspartate-mediated presynaptic inhibition. Neuroscience 1999;92:1261-1272.
36. Lee HK, Kameyama K, Huganir RL, Bear MF. NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus. Neuron 1998;21:1151-1162.
37. Bourtchuladze R, Frenguelli B, Blendy J, et al. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994;79:59-68.
38. Frank DA, Greenberg ME. CREB: a mediator of long-term memory from mollusks to mammals. Cell 1994;79:5-8.
39. Stevens CF. CREB and memory consolidation. Neuron 1994; 13:769-770.
40. Gelbard HA, Epstein LG. HIV-1 encephalopathy in children. Curr Opin Pediatr 1995;7:655-662.